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ABSTRACT  The  dwarf mutation  in  mice  interferes with the  development  of those  anterior 
pituitary  cells responsible for production of thyroid stimulating  hormone,  growth hormone, 
and prolactin.  Myosin isozyme transitions in both cardiac and skeletal muscle were also found 
to be affected  in this mutant.  Electrophoresis of native myosins demonstrated  that the fetal 
(V3) to adult (V1) ventricular cardiac isozyme transition was completely  blocked in dwarf mice; 
in contrast, the neonatal to adult fast myosin transition in hind limb skeletal muscle was slowed 
but not totally  inhibited.  The persistence of neonatal myosin heavy chain for up to 55-75 d 
after birth  in dwarf mice, as compared with 16 d in normal mice, was directly  demonstrated 
by polypeptide and  immunopolypeptide  mapping. Morphological  examination  of  18-36-d- 
old dwarf skeletal muscles by optical and electron microscopy revealed a relative immaturity, 
but no signs of gross pathology were evident.  Immunocytochemical  analysis showed that the 
abnormal  persistence of neonatal myosin occurs in most of the fibers. Multiple injections of 
thyroxine  restored a normal isozyme complement  to both cardiac and skeletal muscles within 
11-15 d. Therefore, the effects of the dwarf mutation  on myosin isozymes can be explained 
by the lack of thyroid hormone in these animals. Because the synthesis of growth hormone  is 
not  stimulated  by thyroid  hormone  in  dwarf mice as it would be in  normal animals, these 
results demonstrate that thyroid hormone  promotes myosin isozyme transitions independent 
of growth hormone production. 
Six or more different isoforms of the myosin heavy chain can 
be found  in  mammalian cardiac and  skeletal  muscles. Al- 
though  their  structures  are  very  homologous,  these  heavy 
chains are distinct polypeptides as shown by protein chemical, 
immunochemical, and molecular cloning approaches (5,  14, 
16,  19, 20, 25, 29, 35, 41, 43, 44, 47). In both developing and 
adult muscles, transitions between different myosin isoforms 
take place within  the same cardiac cells  or skeletal muscle 
fibers (7,  8,  32,  34).  The control of these transitions has in 
several cases been shown to be modulated by factors external 
to the muscle cell,  although the nature of these controlling 
influences  is  known  in  general  outline  only  (reviewed  in 
reference  42).  Some  myosin  transitions  require  a  specific 
innervation or nerve-activity pattern (23,  33), whereas others 
can occur in the absence ofinnervation (8,  17). The hormonal 
status of the animal can also influence the type of myosin 
isozyme present. 
Hypothyroidism has been shown to inhibit certain myosin 
isozyme transitions  that  normally take  place during  roam- 
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malian skeletal and cardiac muscle development (9,  13,  17, 
30). However, thyroid hormone levels also contribute to the 
regulation of the postnatal increase in growth hormone (36), 
and growth hormone has effects on skeletal growth, at least 
some of which are mediated via the action of somatomedins 
(27).  It is therefore not clear from previous results whether 
the inhibition  of myosin transitions produced by hypothy- 
roidism is a result of the lack of thyroid hormone, or whether 
it is a secondary effect due to lowered growth hormone levels. 
To investigate this question, we have studied myosin iso- 
zyme transitions in a mouse model of pituitary dwarfism. The 
dwarf mutation in mice (39) interfers with the development 
of those anterior pituitary cells that normally produce thyroid 
stimulating  hormone (TSH), t  growth  hormone (GH),  and 
prolactin (4). As a result, these hormones are present at low 
levels in  the  sera of homozygous dwarf mice.  In addition, 
~Abbreviations  used  in  this paper:  GH, growth hormone;  TSH, 
thyroid stimulating hormone. 
603 synthesis of GH is undetectable in the pituitary at all ages (12, 
37, 38), and exogenous thyroid hormone does not stimulate 
GH  production  (37).  Dwarf mice  are  therefore  a  suitable 
model of the hypothyroid state that is not complicated by the 
stimulatory effects of thyroid hormone on GH production. 
We have found that the normal developmental appearance 
of the  adult  cardiac  myosin  isozyme is  inhibited  in  these 
animals. In contrast, accumulation of the adult skeletal mus- 
cle myosin forms is slowed but not completely blocked. Both 
of  these developmental defects can be overcome by exogenous 
thyroxine. Since dwarf mice lack GH-producing somatotropes 
(12,  31, 38), these results demonstrate that thyroid hormone 
does  not  affect myosin isozyme transitions  by stimulating 
growth hormone production. 
MATERIALS  AND  METHODS 
Mice of the  Snell dwarf strain (4,  12) were  used in this study. Optical and 
electron microscopy of fixed extensor digitorum longus muscles was performed 
using standard techniques (15) on dwarf and control mice of various ages, as 
follows: 18 d  (five dwarfs and three controls), 24-25 d  (six dwarfs and eight 
controls), and 31-36 d (three dwarfs and four controls). For electrophoresis of 
native myosin, muscle tissue from individual mice was extracted and prepared 
as described (7); the skeletal muscle extracts were made from the gastrocnemius 
muscles. Myosin was purified (5)  using hind leg muscles pooled from several 
mice for a given age point. The myosins were denatured with SDS and cleaved 
with chymotrypsin as described previously (5, 43). The resulting polypeptides 
were separated on duplicate SDS-containing 10% polyacrylamide  gels. One gel 
was stained with Coomassie Blue and the other was blotted onto a nitrocellulose 
sheet as described (6),  except that 0.1% SDS was included in the buffer used 
for the electrophoretic transfer step and electrophoresis was carded out for 18- 
20 h.  The nitrocellulose sheet was then treated and reacted with an antibody 
specific to rat neonatal myosin as described (7).  Indirect immunofluorescence 
on gastrocnemius muscles was performed  using rabbit antibodies to rat fast 
and neonatal myosins, prepared and characterized as described (7);  a  rhoda- 
mine-conjugated goat anti-rabbit immunoglobulin preparation (Nordic,  Til- 
burg,  The  Netherlands) was  used  as a  second  antibody.  For  the  hormone 
supplementation experiments, dwarf mice of-5 g body wt were injected every 
2-3 d with 1 ug L-thyroxine (Sigma Chemical Co., St. Louis, MO) dissolved in 
0.1  ml of 0.14 M  NaCI,  10 mM sodium phosphate, pH 8.5. After 11-15 d  of 
treatment, the native myosin isozymes were analyzed by electrophoresis. 
RESULTS 
Two ventricular cardiac myosin heavy chains, which combine 
to give rise to three bands in native electrophoresis, called V 1, 
V2, and V3 (14, 20, 35), have been identified in all mammals 
examined (14, 20, 24,  35). In rats and mice, the V3 homodi- 
mer is predominant in fetal hearts but is replaced by the V1 
homodimer within the first few weeks after birth (24, 35). 
Fig. 1, lane a shows the analysis of  a 10-d-old control mouse 
heart that contains one band corresponding to the V 1 form 
(Fig.  1, lane a). In the hearts of dwarf mice, one major band 
of ventricular myosin is observed by nondenaturing gel elec- 
trophoresis in all animals examined between the ages of 10 
and 70 d; examples are shown for I0, 50, and 70 d  (Fig.  1, 
lanes  b-d).  Co-migration  with  myosin  from  control  adult 
hearts indicates that the dwarf isozyme is the V3  form (Fig. 
1, lane e). The myosin light chain complement of control and 
dwarf hearts is the same, as determined by two-dimensional 
gel  electrophoresis (not  shown).  Therefore, the  VI  and  V3 
bands  detected  by  nondenaturing  electrophoresis probably 
reflect the presence of different heavy chain types, as expected 
from previous results (14, 20, 35). Since the limit of detection 
of this technique is -5% (26), we cannot rule out the presence 
of V1  and V2 in dwarf mice at these levels. Nonetheless it is 
clear that  the  fetal  V3  cardiac  myosin  isozyme persists  in 
these dwarf mice up to at least 70 d of age, and the adult V 1 
form never appears during this time in quantities detectable 
by the native electrophoretic technique. 
In  newborn  rats  and  mice,  the  major  myosin  isozyme 
present in developing skeletal muscle fibers has been referred 
to as neonatal myosin (44,  45).  Protein chemical, immuno- 
chemical, and  molecular cloning results have demonstrated 
that the heavy chain subunit of the rat neonatal  isozyme is 
distinct from the adult heavy chain forms (5,  29,  44).  After 
electrophoresis of native myosin,  three bands  are  seen  for 
both the neonatal and adult myosins (Fig. 2, lanes a and d), 
which  correspond  to  the  isoenzymes  formed  between  the 
heavy chains and the two types of nonphosphorylatable light 
chains that can associate with both heavy chain forms (19). 
During normal mouse muscle development, adult fast myosin 
appears and  eventually replaces the  neonatal  form (Fig.  2, 
lanes a-d).  Based  on  this analysis, adult  myosin begins to 
appear at ~7 d (Fig. 2, lane b), is predominant by 10 d (Fig. 
2, lane c), and is the only form detectable throughout adult- 
hood. The presence of neonatal myosin can be detected up to 
15 d after birth (not shown). 
In skeletal muscles of dwarf mice analyzed by the same gel 
electrophoretic technique, bands that appear to correspond to 
adult myosin can be seen at  10 d (the earliest age examined) 
(Fig. 2, lane e). However, neonatal myosin is also present up 
to 5-6 wk of age; Fig.  2, lanesfand g, shows the results for 
26 and 39 d of  age. The multiple bands must reflect differences 
in the heavy chains since the myosin light chains present in 
FIGURE  1  Electrophoretic anal- 
ysis  of  native  myosin  isozymes 
present  in  ventricular  cardiac 
muscles  of  control  and  dwarf 
mice  of  different  ages.  Results 
are shown for hearts taken from 
a  10-d-old control  mouse (lane 
a)  and  from  dwarf  mice  10  d 
(lane b),  50 d  (lane c), and  70 d 
(lane d)  old.  Analysis of a  mix- 
ture of the 70-d-old dwarf and a 
32 d-old control is shown in lane 
e  the  bands  corresponding Io 
the VI  and V3  isozymes are in- 
dicated. 
FIGURE  2  Electrophoretic analysis of native myosin isozymes pres- 
ent ill control and dwarf skeletal muscles at different ages. The ages 
examined for the control mice are 4  d  (lane a),  7 d  (lane b),  10 d 
(lane c), and 26 d  (lane d).  For the dwarf mice, the ages were  TO d 
(lane e), 26 d  (lane f),  39 d  (lane g),  and 70 d  (lane h).  The bands 
c~rresponding to neonatal (N) and adult fast  (F)  myosin isozymes 
,ue indicated. 
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spond to the three adult fast-type light chains, as determined 
by two-dimensional gel electrophoresis (not shown). Neonatal 
myosin is undetectable only in 60-70-d-old dwarf mice (Fig. 
2,  lane  h),  the  oldest  animals that  were  examined  by this 
technique.  The transition  from neonatal to adult myosin is 
therefore slower in dwarf mice since a  mixture of these two 
myosins can be detected over a longer period than in control 
mice. 
To demonstrate directly the presence of neonatal and adult 
fast myosin  heavy chains,  we  used  a  polypeptide mapping 
approach (43,  44).  Myosin was purified from control mice 4, 
7,  16, 26, and 35 d old, and from dwarf mice 16, 26,  35,  55, 
and 75 d old. These myosins were subjected to partial diges- 
tion with chymotrypsin in the presence of SDS. The resulting 
polypeptide maps demonstrate that the cleavage [aatterns  of 
mouse  neonatal  and  adult  myosin  heavy  chain  types  are 
different (compare Fig.  3, lanes a  and e). Beginning at  16 d 
of age in normal mice, the cleavage pattern is principally that 
of the adult heavy chain (Fig.  3,  lane c). In contrast, bands 
corresponding to neonatal heavy chain can he detected in the 
polypeptide pattern of dwarf muscle myosin up to 55 d (Fig. 
3,  lanes f-i).  Adult  myosin  heavy chain  cleavage products 
begin to be detected in the dwarf myosin at 26 d, and by 55 
d the pattern is predominantly that of adult fast heavy chain 
(Fig.3,  lanes g-j). 
Since a major heavy chain component present in the cleav- 
age pattern  can  mask minor heavy chain types, we used a 
more sensitive way to detect the presence of neonatal myosin 
heavy chain. We prepared blot transfers of the cleavage prod- 
ucts  and  then  reacted  them  with  an  antibody  specific  for 
neonatal myosin (7).  These immunopolypeptide maps dem- 
onstrate  that  neonatal  heavy  chain  cleavage  products  are 
present  in  control  mice  at  4  and  7  d  of age  but  barely 
detectable  at  16  d  (Fig.  3,  lanes  a'-c').  No  polypeptides 
characteristic of neonatal heavy chain are detected at 26 or 
35 d  (Fig.  3, lanes d' and e'). In contrast, neonatal myosin 
heavy chain is clearly present in dwarf muscles up to at least 
75 d of age (the oldest animals examined; Fig. 3, lanesf'-j'). 
As judged from the intensities of the antibody reactions, the 
75-d-old dwarf mice appear to contain  neonatal  myosin in 
amounts similar to those of 16-d-old control animals (com- 
pare Fig.  3, lanes c' and j'). Thus, electrophoresis of native 
myosin, polypeptide mapping, and immunoblotting all indi- 
cate that neonatal heavy chain is present for an abnormally 
long period in dwarf mice but that the adult myosin heavy 
chain nonetheless appears. 
We investigated whether the presence of neonatal myosin 
in dwarf mice older than  16 d was due to a small number of 
immature or pathological fibers in otherwise normal muscle, 
or whether it was a general phenomenon that affected most 
or  all  fibers.  Electron  microscopic  examination  of dwarf 
mouse muscle from 14 animals between 18 and 36 d old (see 
Materials and Methods) demonstrated that no gross patholog- 
ical  features  were  evident.  The  dwarf muscles  were  more 
immature than their age-matched controls in that some cen- 
tral nuclei and apparently migrating nuclei were seen and the 
sarcoplasmic reticulum was less extensive. However, no my- 
oblasts or myotubes were evident in dwarf muscles, the my- 
ofibrils were densely packed and well aligned, and the nerve- 
muscle junctions had well-developed secondary folds.  Dense 
accumulations of glycogen were present in the I-band region 
of dwarf muscles, whereas control muscles had relatively few 
glycogen granules (Fig.  4,  A  and  B).  These  accumulations 
were particularly evident at 18 d of age and are similar to the 
levels normally found in  fetal mouse muscle. Although the 
fibers in dwarf muscles were about one-half to one-third the 
diameter of control  muscle  fibers between days  18  and  31 
FIGURE  3  Polypeptide and  immunopolypeptide mapping of  myosin  heavy  chains  present  in  skeletal  muscles of control  and 
dwarf mice of different ages.  Lanes  a-j are Coomassie Blue-stained proteins. The antibody reaction was detected by  indirect 
immunoperoxidase staining; this is shown in lanes a'-j'. The myosins used were from control mice 4 d (lanes a and a'), 7 d (lanes 
b and b'), 16 d  (lanes c and c'), 26 d  (lanes d and d') and 35 d (lanes e and e') old. Dwarf mouse myosins were from animals 16 
d  (lanes land f'), 26 d  (lanes g and g'), 35 d (lanes h and h'), 55 d  (lanes i and i'), and 75 d  (lanes i and j') old. The position of 
the  Lel  myosin  light chain  is  indicated  by the arrow to the  left  of the  figure; all  polypeptides above this  subunit should  be 
derived from the myosin heavy chain. 
WHALEN ET AL.  Myosin  Isozyme Transition~ in Dwarf Mice  605 FIGURE  4  Morphological appearance of dwarf and control mouse skeletal muscle. Electron micrographs of longitudinal sections 
prepared from animals 18 d old are shown for dwarf (A) and control (B) mouse extensor digitorum longus muscle. Bar in B,  1 #m. 
Transverse sections prepared from M-d-old  dwarf (C) and control (D)  mice were stained with toluidine blue and photographed 
in the optical microscope.  Bar in D, 50 ~m. 
(Fig. 4, C and D), we found no signs of muscle fiber necrosis 
or regeneration. Thus, the dwarf muscles present a morphol- 
ogy that is less mature than that of control muscles, particu- 
larly with  respect  to  fiber diameter and  glycogen content. 
However, no obvious signs of muscle pathology are observed 
at up to 36 d of age. 
We used immunocytochemistry to determine the myosin 
types present in individual fibers of  the gastrocnemius muscles 
of 5-wk-old dwarf mice. At these ages,  most of the fibers of 
control muscles are strongly stained with antibody to adult 
fast myosin (Fig.  5A), whereas neonatal antibody reacts only 
weakly with the smallest-diameter fibers (Fig.  5 B).  In dwarf 
muscles, most fibers show some reactivity with the fast anti- 
body  and  many  fibers  are  strongly  stained  (Fig.  5 C).  In 
contrast  to  control  muscles  however,  almost all  fibers are 
stained with the neonatal antibody (Fig.  5D). Thus, the per- 
sistence of neonatal myosin in dwarf muscles, demonstrated 
by biochemical techniques, reflects its presence in most mus- 
cle fibers, and not just the presence of a small population of 
fibers containing this myosin. 
Since  dwarf mice  are  deficient  in  TSH  (4,  31)  and  are 
hypothyroid from birth (10),  we have investigated whether 
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exogenous thyroid  hormone  is  sufficient  to  overcome the 
block in the cardiac isozyme transition, and whether it would 
affect the skeletal muscle isozyme complement. Animals 3-4 
wk old (~5 g) were injected intraperitoneatly with  1 #g thy- 
roxine every 2-3 d; this amount produces a hyperthyroid state 
through most of the interval between injections, judging from 
previous  studies  of  thyroid  hormone  supplementation  in 
dwarf mice (10).  After  11-15 d  of treatment, an essentially 
complete transition from the V3 to VI cardiac isozyme was 
observed, as determined by electrophoresis of native myosin 
(Fig. 6, lanes a-c). 
Thyroxine injections also affect the myosin isozyme content 
of dwarf skeletal muscles. In the dwarf mice injected for 11- 
15 d, electrophoresis of native myosin shows that the neonatal 
isozymes have almost completely disappeared (Fig. 6, lane e), 
whereas in  uninjected  dwarfs of the  same age the  neonatal 
myosin bands are clearly present (Fig. 6, lane d). The electro- 
phoretic pattern of the myosin from the injected mice now 
resembles that of control animals of a similar age (Fig. 6, lane 
f). Predominantly adult myosin isozymes were found in the 
skeletal and cardiac muscles in all of 13 animals injected for 
11-15 d with thyroxine. FIGURE  5  Indirect immunofluorescence on  serial  sections of skeletal muscle using antibodies to  myosin. The  gastrocnemius 
muscle was taken from 36-d-old control (A and B) and dwarf (C and D) mice, and serial sections were reacted with antibodies to 
either adult fast (A and C) or neonatal (B and D) myosins. The same region of the section is shown in A and B and in C and D, 
and therefore the myosin types present in individual fibers can be determined. Fibers that did not react with either antibody in 
the two sets of photos were observed in serial sections to be stained with antibody to slow myosin (not shown). Bar,  100 ~m. 
×  167. 
DISCUSSION 
In the mouse model of hereditary pituitary dwarfism studied 
here,  the  dwarf phenotype  is  associated with  an  abnormal 
presence of fetal V3 myosin in the heart and an abnormally 
stow transition  from neonatal  to adult  myosin isozymes in 
hind limb skeletal muscles. Thus, this dwarf syndrome affects 
the two striated muscles differently, since the skeletal muscle 
isozyme transition  is only slowed, whereas the cardiac tran- 
sition is apparently completely blocked. In the dwarf skeletal 
muscles, no gross pathology was apparent, nor was there any 
evidence of degeneration or regeneration. The fibers do show 
general signs of immaturity consistent with the overall retar- 
dation of  development expected to be associated with pituitary 
dwarfism. Immunocytochemistry demonstrated that the ab- 
normal peristence of neonatal myosin in these mutant mice 
occurs in most of the muscle fibers rather than being localized 
to a discrete fiber population. 
The  effects of pituitary  dwarfism  on  myosin  transitions 
must be secondary to the primary action of the dwarf muta- 
tion, which is known to affect the development of hormone- 
producing cells in the anterior pituitary, including the thyro- 
tropes responsible for TSH production (4,  31,  46).  The fact 
that an apparently normal isozyme complement can be re- 
stored to both types of striated muscle by injections of thy- 
roxine suggests that it is the lack of thyroid hormone in dwarf 
mice that is responsible for the persistence of these fetal and 
neonatal myosin forms. For certain other phenotypic effects 
of the dwarf mutation, supplementation by one hormone is 
not sufficient to provoke a corrective response. For example, 
the morphology of the thyroid gland is not affected by thy- 
roxine and only slightly modified by injection of TSH. How- 
ever, administration of both TSH and GH results in consid- 
erable improvement in the structure of the gland (1-3). Like- 
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skeletal  and  cardiac  myosin  isozymes  in 
thyroxine-treated dwarf  mice.  In  the  re- 
sults  shown  here,  dwarf  mice  were  in- 
jected with thyroxine every 2-3 d for 11 d 
beginning at 27 d  of age. The cardiac iso- 
zymes  are  shown  for  a  38-d-old  nonin- 
jected dwarf (lane a) and an injected dwarf 
mouse (lane b). The two extracts shown in 
lanes a and b were mixed and analyzed in 
lane c. The skeletal muscle isozymes pres- 
ent in a 38-d-old  noninjected dwarf litter- 
mate are  shown  in  lane d.  The isozymes 
present in the injected dwarf are shown in 
lane e, those in a 38-d-old control mouse 
in lane L 
wise, growth stimulation in dwarf mice has been reported to 
be more effective when both thyroid hormone and GH are 
used (2). 
Previous studies of the effect of hypothyroidism on myosin 
isozyme transitions in developing animals have depended on 
inducing the hypothyroid state by treatment with antithyroid 
drugs (9,  13,  17,  30).  However, in normal animals the post- 
natal increase of GH is dependent  on  increases in  thyroid 
hormone levels (36).  Thus, when the  stimulatory effects of 
thyroid hormone supplementation are investigated in drug- 
treated animals, the addition of exogenous thyroid hormone 
has direct effects as well as extensive indirect effects as a result 
of the  stimulation of GH production (11,  18,  28,  36).  It is 
therefore difficult to distinguish the effects of thyroxine from 
those of growth hormone in these situations. However, using 
the dwarf mouse as a model of the hypothyroid state in which 
GH is not produced in the pituitary either endogenously (12, 
31,  37,  38) or in  response to thyroxine treatment (37),  we 
have been able to demonstrate that the addition of exogenous 
thyroxine has an effect on myosin isozyme transitions that is 
independent of GH production. 
Although  these  results  suggest  that  thyroid  hormone-in- 
duced  GH  production  does  not  play a  role  in  controlling 
myosin isozyme transitions, it cannot be determined whether 
thyroid hormone acts directly on  muscle tissue to exert its 
effects on  myosin  metabolism.  The  role of interactions  of 
thyroid hormone with other hormonal systems or with tissues 
other than muscle remains to be studied.  For example, an- 
other possibility would involve a retarded development of the 
nervous system, which  is a  well-known consequence  of hy- 
pothyroidism  (22).  Although  the  appearance  of adult  fast 
myosin does not require continued innervation (8, 17), under- 
developed motor nerves  might negatively influence muscle 
fiber development. 
The  effects  of  hypothyroidism  on  the  myosin  isozyme 
transitions in dwarf mice are apparently different for the two 
muscle tissues:  the  cardiac  isozyme transition  seems to  be 
completely blocked whereas the neonatal to adult fast myosin 
transition in skeletal muscles clearly takes place, although at 
a slower rate than in normal mice. As compared with results 
of previous studies  on  rats in  which  both transitions  were 
blocked by chemically induced  hypothyroidism (9,  13,  17, 
30), this result in dwarf mice was unexpected. The effects of 
hypothyroidism in dwarf mice could be explained if different 
levels  of thyroid  hormone  were  required  to  promote  the 
myosin transitions in  the two muscle tissues.  Alternatively, 
the neonatal to adult fast myosin transition in skeletal muscle 
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might be under the control of a mechanism that is independ- 
ent  of but facilitated by thyroid hormone.  In this case, the 
thyroxine-induced  acceleration  of this  transition  could  be 
explained  by  the  ability  of thyroid  hormone  to  generally 
stimulate metabolic rate. 
Dwarf mice represent the first description of a genetically 
determined condition  in  which cardiac and skeletal myosin 
isozyme transitions are also affected. This model should allow 
detailed study of the endocrinological control of adult myosin 
appearance since certain myosin transitions can be completely 
and  rapidly  induced  by  exogenous  thyroxine  without  the 
complicating effects of interaction of this hormone with pi- 
tuitary somatotropes. The potential myopathic changes due 
to chronic pituitary hormone abnormalities (21) can he easily 
studied in this animal model. Conversely, the dwarf pheno- 
type may have beneficial effects on certain muscles diseases: 
it was reported that the muscles of doubly homozygous dwarf- 
dystrophic mice do not undergo the myopathic changes char- 
acteristic of dystrophic mouse muscle (40). A case of a human 
pituitary dwarf simultaneously affected by Duchenne  mus- 
cular dystrophy was also described (48); this patient has not 
shown  the  usual  degenerative changes  associated  with  this 
disease.  Dwarf mice may therefore prove useful  in  testing 
certain ideas about possible effects of pituitary hormones, or 
even growth in general, on the progress of muscle disease. 
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